PALI is Palisade Bio, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.99. Market cap: $342M. Capital Quality Rank: 28/100 — Capital destroyer.
Stock snapshot
| Price | $1.99 |
| Market cap | $342M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 28 / 100 · Capital destroyer |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Safe |
About PALI
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Related non-dividend companies
Other non-dividend stocks investors research alongside PALI. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is PALI's current stock price?
PALI (Palisade Bio, Inc.) is currently trading at $1.99.
Does PALI pay a dividend?
PALI (Palisade Bio, Inc.) does not currently pay a regular dividend.
What is PALI's Capital Quality Rank?
PALI has a Capital Quality Rank of 28/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track PALI in DiviDrip
Add PALI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search PALI and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.
